Ændring fra baseline i samlet YMRS- score viste fortsat bedring og var i uge 12 sammenlignelig mellem risperidon og haloperidol.
Change from baseline in total YMRS showed continued improvement and was comparable between risperidone and haloperidol at Week 12.